Tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate
C26H30N6O4S — CID 71061211
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate
Tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate (PubChem CID 71061211) has the molecular formula C26H30N6O4S and a molecular weight of 522.63 g/mol. Its IUPAC name is tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 71061211 |
| Molecular Formula | C26H30N6O4S |
| Molecular Weight | 522.63 g/mol |
| Exact Mass | 522.20 |
| IUPAC Name | tert-butyl 4-[[4-[(4-carbamoyl-2-pyridin-4-yl-1,3-thiazol-5-yl)carbamoyl]phenyl]methyl]piperazine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1 |
| InChI | InChI=1S/C26H30N6O4S/c1-26(2,3)36-25(35)32-14-12-31(13-15-32)16-17-4-6-18(7-5-17)22(34)30-24-20(21(27)33)29-23(37-24)19-8-10-28-11-9-19/h4-11H,12-16H2,1-3H3,(H2,27,33)(H,30,34) |
| InChIKey | MZMUUNMNMUNYMB-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 130.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 522.63 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71061211 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.